Funder: Food and Drug Administration (FDA)
Due Dates: Archived as of May 26, 2021 (no current deadlines)
Funding Amounts: Not specified; cooperative agreement funding mechanism
Summary: Supports innovative clinical trial designs and strategic collaborations to advance development of analgesic, anesthetic, addiction, and peripheral neuropathy medications.
Key Information: Multi-year, multi-phase public-private partnership aligned with FDA's Critical Path Initiative; no current open application period.